The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Intraarterial high-dose cisplatinum (IAHDP) as a part of the treatment of relapsed or locally advanced tumors of the head and neck (H&N): A feasibility study.
Manuel Sureda Gonzalez
No relevant relationships to disclose
Antonio Moreno
No relevant relationships to disclose
Joseba Rebollo
No relevant relationships to disclose
A. Brugarolas
No relevant relationships to disclose
Rosa CaƱon
No relevant relationships to disclose
Ignacio Azinovic
No relevant relationships to disclose
Aurora Crespo
No relevant relationships to disclose